The level of plasma EV-derived MARCKSL1 in nonmetastatic CRC patients was also higher than that in healthy subjects, but no significant difference was found (P > 0.05) (Fig. 2). The gene discussed is MARCKSL1; the disease is colorectal carcinoma.